Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 137
of 7Next
1:

The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy.

Gooden KM, Howard DL, Carpenter WR, Carson AP, Taylor YJ, Peacock S, Godley PA.

Med Care. 2008 Nov;46(11):1170-6.

PMID: 18953228 [PubMed - indexed for MEDLINE]

2:

[Cae of double cancer involving of the bladder and prostate which was treated by radical cystectomy 8 years after radical prostatectomy]

Tamura Y, Ohki K, Sasaki Y, Ohtake N, Ohnuki T, Kurokawa K.

Nippon Hinyokika Gakkai Zasshi. 2008 Sep;99(6):694-7. Japanese.

PMID: 18939452 [PubMed - indexed for MEDLINE]

3:

Effects of provision and receipt of social support on adjustment to laparoscopic radical prostatectomy.

Scholz U, Knoll N, Roigas J, Gralla O.

Anxiety Stress Coping. 2008 Jul;21(3):227-41.

PMID: 18938287 [PubMed - indexed for MEDLINE]

4:

Is PTEN loss associated with clinical outcome measures in human prostate cancer?

McCall P, Witton CJ, Grimsley S, Nielsen KV, Edwards J.

Br J Cancer. 2008 Oct 21;99(8):1296-301.

PMID: 18854827 [PubMed - indexed for MEDLINE]

5:

Definitive radiotherapy for prostate cancer.

Mendenhall WM, Henderson RH, Mendenhall NP.

Am J Clin Oncol. 2008 Oct;31(5):496-503. Review.

PMID: 18838889 [PubMed - indexed for MEDLINE]

6:

Radical prostatectomy.

Hammad FT.

Ann N Y Acad Sci. 2008 Sep;1138:267-77. Review.

PMID: 18837906 [PubMed - indexed for MEDLINE]

7:

Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.

Shah JN, Shao G, Hei TK, Zhao Y.

BMC Cancer. 2008 Oct 3;8:284.

PMID: 18834524 [PubMed - indexed for MEDLINE]

8:

Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.

Riley GF, Warren JL, Potosky AL, Klabunde CN, Harlan LC, Osswald MB.

Med Care. 2008 Oct;46(10):1108-15.

PMID: 18815533 [PubMed - indexed for MEDLINE]

9:

The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy.

Mao K, Badoual C, Camparo P, Delongchamps NB, Vieillefond A, Dinh-Xuan AT, Peyromaure M.

Can J Urol. 2008 Oct;15(5):4257-62.

PMID: 18814815 [PubMed - indexed for MEDLINE]

10:

[Radical prostatectomy--100 years of evolution]

Gofrit ON, Shalhav AL.

Harefuah. 2008 Jul;147(7):639-42, 660. Review. Hebrew.

PMID: 18814526 [PubMed - indexed for MEDLINE]

11:

Robotic equipment malfunction during robotic prostatectomy: a multi-institutional study.

Lavery HJ, Thaly R, Albala D, Ahlering T, Shalhav A, Lee D, Fagin R, Wiklund P, Dasgupta P, Costello AJ, Tewari A, Coughlin G, Patel VR.

J Endourol. 2008 Sep;22(9):2165-8.

PMID: 18811574 [PubMed - indexed for MEDLINE]

12:

The significance of monoamine oxidase-A expression in high grade prostate cancer.

Peehl DM, Coram M, Khine H, Reese S, Nolley R, Zhao H.

J Urol. 2008 Nov;180(5):2206-11. Epub 2008 Sep 20.

PMID: 18804811 [PubMed - indexed for MEDLINE]

13:

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

Whitman EJ, Groskopf J, Ali A, Chen Y, Blase A, Furusato B, Petrovics G, Ibrahim M, Elsamanoudi S, Cullen J, Sesterhenn IA, Brassell S, Rittenhouse H, Srivastava S, McLeod DG.

J Urol. 2008 Nov;180(5):1975-8; discussion 1978-9. Epub 2008 Sep 17.

PMID: 18801539 [PubMed - indexed for MEDLINE]

14:

What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.

Teeter AE, Bañez LL, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ; SEARCH Database Group.

J Urol. 2008 Nov;180(5):1980-4; discussion 1985. Epub 2008 Sep 17.

PMID: 18801519 [PubMed - indexed for MEDLINE]

15:

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. Epub 2008 Sep 17.

PMID: 18801517 [PubMed - indexed for MEDLINE]

16:

Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.

Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD.

J Urol. 2008 Nov;180(5):1964-7; discussion 1967-8. Epub 2008 Sep 17.

PMID: 18801515 [PubMed - indexed for MEDLINE]

17:

Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.

Urba WJ, Nemunaitis J, Marshall F, Smith DC, Hege KM, Ma J, Nguyen M, Small EJ.

J Urol. 2008 Nov;180(5):2011-7; discussion 2017-8. Epub 2008 Sep 17.

PMID: 18801509 [PubMed - indexed for MEDLINE]

18:

Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.

Thomas C, Wiesner C, Melchior S, Gillitzer R, Schmidt F, Thüroff JW.

J Urol. 2008 Nov;180(5):1938-41; discussion 1941. Epub 2008 Sep 17.

PMID: 18801501 [PubMed - indexed for MEDLINE]

19:

[Loss of differentiation of a prostate adenocarcinoma after hormone therapy: the example of a metastasis in the spongy body of the penis]

Uphoff J, Woziwodzki J, Schattka SO, Kollias A.

Aktuelle Urol. 2008 Sep;39(5):373-7. Epub 2008 Sep 16. German.

PMID: 18798127 [PubMed - indexed for MEDLINE]

20:

Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.

Köllermann J, Weikert S, Schostak M, Kempkensteffen C, Kleinschmidt K, Rau T, Pantel K.

J Clin Oncol. 2008 Oct 20;26(30):4928-33. Epub 2008 Sep 15.

PMID: 18794550 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 137
of 7Next